RISK WARNING: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74% and 89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
RISK WARNING: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
Trusted Trading Platform
Free account
Worldwide Trading
Portfolio Management
en
ChatGPT Image 14 okt 2025, 16_38_56

Orion Oyj  

nasdaq Helsinki

Orion Oyj - Class B (ORNBVxhel) is a Finnish pharmaceutical company headquartered in Espoo. The company develops, manufactures, and markets prescription drugs, self-care products, and active pharmaceutical ingredients (APIs). Its key therapeutic areas include oncology, central nervous system disorders, and respiratory diseases, with notable products including Easyhaler inhalers and Stalevo/Comtan for Parkinson's disease. Orion is a constituent of the OMX Helsinki 25 index on Nasdaq Helsinki. The company is a leading pharmaceutical company in the Nordic region and an important player in the European pharma market.

 ORNBV symbol info
 
 


 
Top stories by TradingView
 Technical analysis for ORNBV
 
ORNBV chart

Start trading
Orion Oyj now

At In2Markets, we offer unique strategies designed to align with your goals and adapt to changing market conditions. Our team will provide you with real-time support and expert insights to answer your question in a quick and personal way. Whether you’re trading or managing your portfolio, we combine innovation with a personalized approach to ensure you stay ahead.

Update I2M Telefoon (1)